WallStSmart

Ventas Inc (VTR)vsChiron Real Estate Inc. (XRN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Ventas Inc generates 3829% more annual revenue ($5.82B vs $148.06M). VTR leads profitability with a 4.3% profit margin vs -3.9%. VTR appears more attractively valued with a PEG of 1.74. VTR earns a higher WallStSmart Score of 55/100 (C).

VTR

Buy

55

out of 100

Grade: C

Growth: 7.3Profit: 5.0Value: 4.7Quality: 3.8
Piotroski: 4/9Altman Z: 0.39

XRN

Hold

41

out of 100

Grade: D

Growth: 5.3Profit: 4.5Value: 4.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

VTRSignificantly Overvalued (-578.5%)

Margin of Safety

-578.5%

Fair Value

$12.63

Current Price

$82.50

$69.87 premium

UndervaluedFair: $12.63Overvalued

Intrinsic value data unavailable for XRN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

VTR2 strengths · Avg: 8.0/10
Operating MarginProfitability
20.3%8/10

Strong operational efficiency at 20.3%

Revenue GrowthGrowth
21.4%8/10

Revenue surging 21.4% year-over-year

XRN2 strengths · Avg: 9.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Operating MarginProfitability
25.1%8/10

Strong operational efficiency at 25.1%

Areas to Watch

VTR4 concerns · Avg: 3.0/10
PEG RatioValuation
1.744/10

Expensive relative to growth rate

Return on EquityProfitability
2.2%3/10

ROE of 2.2% — below average capital efficiency

Profit MarginProfitability
4.3%3/10

4.3% margin — thin

P/E RatioValuation
160.0x2/10

Premium valuation, high expectations priced in

XRN4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$934.84M3/10

Smaller company, higher risk/reward

PEG RatioValuation
5.092/10

Expensive relative to growth rate

Return on EquityProfitability
-127.0%2/10

ROE of -127.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : VTR

The strongest argument for VTR centers on Operating Margin, Revenue Growth. Revenue growth of 21.4% demonstrates continued momentum.

Bull Case : XRN

The strongest argument for XRN centers on Price/Book, Operating Margin.

Bear Case : VTR

The primary concerns for VTR are PEG Ratio, Return on Equity, Profit Margin. A P/E of 160.0x leaves little room for execution misses. Thin 4.3% margins leave little buffer for downturns.

Bear Case : XRN

The primary concerns for XRN are EPS Growth, Market Cap, PEG Ratio.

Key Dynamics to Monitor

VTR profiles as a growth stock while XRN is a turnaround play — different risk/reward profiles.

XRN carries more volatility with a beta of 1.21 — expect wider price swings.

VTR is growing revenue faster at 21.4% — sustainability is the question.

VTR generates stronger free cash flow (368M), providing more financial flexibility.

Bottom Line

VTR scores higher overall (55/100 vs 41/100) and 21.4% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Ventas Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Ventas, Inc. is a real estate investment trust specializing in the ownership and management of health care facilities in the United States, Canada and the United Kingdom.

Chiron Real Estate Inc.

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Chiron Real Estate Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Want to dig deeper into these stocks?